GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ODI Pharma AB (XSAT:ODI) » Definitions » Profitability Rank

ODI Pharma AB (XSAT:ODI) Profitability Rank : 1 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is ODI Pharma AB Profitability Rank?

ODI Pharma AB has the Profitability Rank of 1. It has had trouble to make a profit.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

ODI Pharma AB's Operating Margin % for the quarter that ended in Dec. 2023 was 105,900.00%. As of today, ODI Pharma AB's Piotroski F-Score is 5.


Competitive Comparison of ODI Pharma AB's Profitability Rank

For the Drug Manufacturers - Specialty & Generic subindustry, ODI Pharma AB's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ODI Pharma AB's Profitability Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ODI Pharma AB's Profitability Rank distribution charts can be found below:

* The bar in red indicates where ODI Pharma AB's Profitability Rank falls into.



ODI Pharma AB Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

ODI Pharma AB has the Profitability Rank of 1. It has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

ODI Pharma AB's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as:

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=1.059 / 0.001
=105,900.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

ODI Pharma AB has an F-score of 5 indicating the company's financial situation is typical for a stable company.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

4. Consistency of the profitability

5. Predictability Rank


ODI Pharma AB Profitability Rank Related Terms

Thank you for viewing the detailed overview of ODI Pharma AB's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


ODI Pharma AB (XSAT:ODI) Business Description

Traded in Other Exchanges
N/A
Address
Ostermalmstorg 1, Stockholm, SWE, 114 42
ODI Pharma AB is a provider of medicinal cannabis. It offers its products to pharmacies, specialty clinics, and hospitals.

ODI Pharma AB (XSAT:ODI) Headlines

No Headlines